5Mccluggage WG.Magligant biphasic uterine tumours:cacinoscarcomas or metaplastic carcinomas[J]? Clin Patho,2002,55:321-325.
二级参考文献13
1Arrastia C, Fruchter R, Clark M, et al. Uterine carcinosarcomas. Incidence and trends in management and survival [J]. Gynecol Oncol, 1997,65:158 - 163.
2Gourley C, Al-Nafussi A, Abdulksder M, et al. Malignant mixed mesodermal tomours: biology and clinical aspects[J]. Eur J Caner 2002,38: 1437 - 1446.
3Knocke T, Kueera H, Dorfler D, et al. Results of post operative radiotherapy in the treatment of sarcoma of corpus uterine [J]. Cancer, 1998, 83:1972-1979.
4Sutton G, Brunetto U, Kilgore L, et al. A phase Ⅲ trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus : a gynecologic oncology group study [J]. Gynecol Oncol, 2000, 79 : 147 - 153.
5Silverberg S G, Major F J, Blessing J A, et al. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A gynecologic oncology group pathologic study of 203 cases [J]. Int J Gynecol Pathol, 1990, 9: 1 - 19.
6Robboy S J, Anderson M C, Russell P. Pathology of the Female Reproductive Tract [M]. London : Churchill Livingstone, 2002.
7Chuang J T, Van Velden D J, Graham J B. Carcinosarcoma and mixed mesodermal tumor of the uterine corpus. Review of 49 cases [J]. Obstet Gynecol, 1970, 35:769-780.
8Dinh T V, Slavin R E, Bhagavan B S, et al. Mixed me'ullerian tumors of the uterus: a clinicopathologic study[J]. Obstet Gynecol, 1989, 274:388-392.
9Amant F, Cadron I, Fuso L, et al. Endometrial have a different prognosis and pattern of spread compared to high-risk epithelial endometfial cancer [J]. Gynecol Oncol, 2005,98 (2) : 274 -280.
10Macasaet M A, Waxman M, Fruchter R G, et al. Prognostic factors in malignant mesodermal (mullerian) mixed tumors of the uterus[J]. Gynecol Oncol ,1985, 20:32 -42.
